Mirae Asset Global Investments Co., Ltd. Collegium Pharmaceutical, Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,165 shares of COLL stock, worth $40,437. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,165
Previous 977
19.24%
Holding current value
$40,437
Previous $31,000
45.16%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding COLL
# of Institutions
248Shares Held
40.3MCall Options Held
84.2KPut Options Held
19.6K-
Black Rock Inc. New York, NY5.79MShares$201 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA3.41MShares$118 Million0.28% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.63MShares$91.4 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.37MShares$82.3 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY2.33MShares$81 Million2.23% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.18B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...